ISSN 2996-8968
Vol. 9, Issue 1, 2018March 24, 2018 EDT
PEGylated Recombinant Human Hyaluronidase (PEGPH20): transition from a novel functional excipient to an API to increase the chemotherapeutic effectiveness against hyaluronan-rich cancers.
PEGylated Recombinant Human Hyaluronidase (PEGPH20): transition from a novel functional excipient to an API to increase the chemotherapeutic effectiveness against hyaluronan-rich cancers.
Articles in Vol. 9, Issue 1, 2018
Vol. 9, Issue 1, 2018
- PEGylated Recombinant Human Hyaluronidase (PEGPH20): transition from a novel functional excipient to an API to increase the chemotherapeutic effectiveness against hyaluronan-rich cancers.shireesh apte
- EVALUATION OF Passiflora tripartita var. mollisima SEED OIL AS POTENTIAL NANOEMULSION EXCIPIENTDiana Marcela AragónJorge Ariel Martínez-RamírezMaritza Rojas-CardozoJenny Alexandra Hernández
- Flow, compaction and tabletting properties of co-processed excipients of pregelatinized Ofada rice starch and HPMCADENIKE OKUNLOLA
apte, shireesh. 2018. “PEGylated Recombinant Human Hyaluronidase (PEGPH20): Transition from a Novel Functional Excipient to an API to Increase the Chemotherapeutic Effectiveness against Hyaluronan-Rich Cancers.” International Journal of Pharmaceutical Excipients 9 (1). https://doi.org/10.66617/001c.3407.